Skip to main content
SpringerLink
Log in

Monophasische orale Kontrazeptiva im Langzyklus

Monophasic oral contraceptives in the extended cycle regimen

  • Zum Thema
  • Published:
Der Gynäkologe Aims and scope

Zusammenfassung

Orale Kontrazeptiva werden konventionell über jeweils 21 Tage eingenommen, gefolgt von einer einwöchigen Einnahmepause. Diese Einnahmepause führt zu einem als natürlich empfundenen monatlichen Blutungsmuster, ist jedoch physiologisch nicht notwendig und bei manchen Frauen mit erheblichen Beschwerden verbunden. Die vorliegende Arbeit erläutert die theoretischen Grundlagen des Langzyklus-Konzepts, d. h. der kontinuierlichen Einnahme über einen längeren Zeitraum, und fasst die bisherigen praktischen Erfahrungen zusammen.

Abstract

Oral contraceptives are usually taken for 21 days followed by a 7 day pill-free interval. This interval results in a monthly bleeding pattern that is perceived as natural but which is not physiologically necessary and in some women is even associated with considerable discomfort. The present paper explains the theoretical background of the extended cycle regimen (i.e. the continuous intake over a longer period of time) and reviews the practical experience available to date.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Anderson FD, Gibbons W, Portman D (2006) Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol. Contraception 73(3): 229–234

    Article  PubMed  Google Scholar 

  2. Anderson FD, Hait H (2003) A multicenter, randomized study of an extended cycle oral contraceptive. Contraception 68(2): 89–96

    Article  PubMed  Google Scholar 

  3. Edelman AB, Gallo MF, Jensen JT et al. (2005) Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception. Cochrane Database Syst Rev 20(3): CD004695

    Google Scholar 

  4. ESHRE Capri Workshop Group (2001) Ovarian and endometrial function during hormonal contraception. Hum Reprod 16(7): 1527–1535

    Article  PubMed  Google Scholar 

  5. ESHRE Capri Workshop Group (2005) Noncontraceptive health benefits of combined oral contraception. Hum Reprod Update 11(5): 513–525

    Article  PubMed  Google Scholar 

  6. Gladwell M (2000) John Rock’s error. New Yorker (13. März) pp 52–63

  7. Kwiecien M, Edelman A, Nichols MD et al. (2003) Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Contraception 67(1): 9–13

    Article  PubMed  Google Scholar 

  8. Landgren BM, Csemiczky G (1991) The effect of follicular growth and luteal function of „missing the pill“. A comparison between a monophasic and a triphasic combined oral contraceptive. Contraception 43(2): 149–159

    Article  PubMed  Google Scholar 

  9. Loder EW, Buse DC, Golub JR (2005) Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review. Am J Obstet Gynecol 193(3 Pt 1): 636–649

    Article  PubMed  Google Scholar 

  10. Miller L, Hughes JP (2003) Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial. Obstet Gynecol 101(4): 653–661

    Article  PubMed  Google Scholar 

  11. Miller L, Notter KM (2001) Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial. Obstet Gynecol 98(5 Pt 1): 771–778

    Article  PubMed  Google Scholar 

  12. Schlaff WD, Lynch AM, Hughes HD et al. (2004) Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression. Am J Obstet Gynecol 190(4): 943–951

    Article  PubMed  Google Scholar 

  13. Schultz-Zehden B, Boschitsch E (2006) Perception and satisfaction with Yasmin use in clinical practice. Treatments Endocrinol

  14. Short RV (1985) Breast-feeding: nature’s contraceptive. Network 5(1): 4

    PubMed  Google Scholar 

  15. Sillem M, Schneidereit R, Heithecker R et al. (2003) Use of an oral contraceptive containing drospirenone in an extended regimen. Eur J Contracept Reprod Health Care 8(3): 162–169

    PubMed  Google Scholar 

  16. Spona J, Elstein M, Feichtinger W et al. (1996) Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception 54(2): 71–77

    Article  PubMed  Google Scholar 

  17. Sulak PJ, Cressman BE, Waldrop E et al. (1997) Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol 89(2): 179–183

    Article  PubMed  Google Scholar 

  18. Sulak PJ, Kuehl TJ, Coffee A et al. (2006) Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen. Am J Obstet Gynecol

  19. Sulak PJ, Scow RD, Preece C et al. (2000) Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 95(2): 261–266

    Article  PubMed  Google Scholar 

  20. Sullivan H, Furniss H, Spona J et al. (1999) Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity. Fertil Steril 72(1): 115–120

    Article  PubMed  Google Scholar 

  21. Vercellini P, Frontino G, De Giorgi O et al. (2003) Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 80(3): 560–563

    Article  PubMed  Google Scholar 

  22. Wiegratz I, Hommel HH, Zimmermann T et al. (2004) Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception 69(1): 37–42

    Article  PubMed  Google Scholar 

  23. Wiegratz I, Kuhl H (2004) Long-cycle treatment with oral contraceptives. Drugs 64(21): 2447–2462

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf eine Verbindung mit folgender Firma/Firmen hin: Regelmäßige Vortragstätigkeit für Schering AG und Schering Deutschland GmbH.

Author information

Authors and Affiliations

  1. Abteilung Gynäkologie und Geburtshilfe, Kreiskrankenhaus Emmendingen, Gartenstraße 44, 79312, Emmendingen, Deutschland

    M. Sillem

Authors
  1. M. Sillem
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Sillem.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sillem, M. Monophasische orale Kontrazeptiva im Langzyklus. Gynäkologe 39, 707–711 (2006). https://doi.org/10.1007/s00129-006-1881-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-006-1881-7

Schlüsselwörter

Keywords

Search

Navigation